Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey D Barnes

Showing results (41-50 of 288) with videos related to

Pageof 29
Sort By:
Annals of Internal Medicine|March 15, 2016
Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AFGeoffrey D Barnes, James D Douketis
Annals of Internal Medicine|November 19, 2019
Web Exclusive. Annals for Hospitalists Inpatient Notes - Reaching for Higher Value in Health Care by Bringing Together Clinicians and Researchers-The Michigan Program on Value EnhancementGeoffrey D Barnes, Eve A Kerr
Journal of Thrombosis and Thrombolysis|November 27, 2024
Novel antithrombotic approaches in cardiovascular disease - what is on the horizon?Geoffrey D Barnes, Diana A Gorog
Journal of Thrombosis and Thrombolysis|March 17, 2015
Engaging with quality improvement in anticoagulation managementGeoffrey D Barnes, Eva Kline-Rogers
Research and Practice in Thrombosis and Haemostasis|May 4, 2023
When technology improves patient care and provider experienceGeoffrey D Barnes, Angela C Weyand
Current Cardiology Reports|April 23, 2022
Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart DiseaseGhadeer K Dawwas, Geoffrey D Barnes
Journal of Thrombosis and Thrombolysis|July 19, 2008
Anticoagulation: where we are and where we need to goGeoffrey D Barnes, James B Froehlich
Annals of Internal Medicine|June 20, 2022
Web Exclusive. Annals for Hospitalists Inpatient Notes - Venous Thromboembolism Prophylaxis in COVID-19: Making Sense of the EvidenceChristopher A Smith, Geoffrey D Barnes
Thrombosis and Haemostasis|June 1, 2024
Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?Jordan K Schaefer, Geoffrey D Barnes
Annual Review of Medicine|July 19, 2022
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic ComplicationCharles S Abrams, Geoffrey D Barnes
Pageof 29

Showing results (41-50 of 288) with videos related to

Sort By:
Pageof 29
Annals of Internal Medicine|March 15, 2016
Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AFGeoffrey D Barnes, James D Douketis
Annals of Internal Medicine|November 19, 2019
Web Exclusive. Annals for Hospitalists Inpatient Notes - Reaching for Higher Value in Health Care by Bringing Together Clinicians and Researchers-The Michigan Program on Value EnhancementGeoffrey D Barnes, Eve A Kerr
Journal of Thrombosis and Thrombolysis|November 27, 2024
Novel antithrombotic approaches in cardiovascular disease - what is on the horizon?Geoffrey D Barnes, Diana A Gorog
Journal of Thrombosis and Thrombolysis|March 17, 2015
Engaging with quality improvement in anticoagulation managementGeoffrey D Barnes, Eva Kline-Rogers
Research and Practice in Thrombosis and Haemostasis|May 4, 2023
When technology improves patient care and provider experienceGeoffrey D Barnes, Angela C Weyand
Current Cardiology Reports|April 23, 2022
Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart DiseaseGhadeer K Dawwas, Geoffrey D Barnes
Journal of Thrombosis and Thrombolysis|July 19, 2008
Anticoagulation: where we are and where we need to goGeoffrey D Barnes, James B Froehlich
Annals of Internal Medicine|June 20, 2022
Web Exclusive. Annals for Hospitalists Inpatient Notes - Venous Thromboembolism Prophylaxis in COVID-19: Making Sense of the EvidenceChristopher A Smith, Geoffrey D Barnes
Thrombosis and Haemostasis|June 1, 2024
Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?Jordan K Schaefer, Geoffrey D Barnes
Annual Review of Medicine|July 19, 2022
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic ComplicationCharles S Abrams, Geoffrey D Barnes
Pageof 29